• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发缓解型多发性硬化症组和临床孤立综合征组的血清25(OH)维生素D水平。

Serum 25(OH) vitamin D level in Relapsing-Remitting Multiple Sclerosis and clinically isolated syndrome groups.

作者信息

Küçük Ahmet, Bir Levent Sinan, Tekin Selma, Demir Süleyman

机构信息

Department of Neurology, Faculty of Medicine, Pamukkale University, Denizli, Turkey.

Department of Medical Biochemistry, Faculty of Medicine, Pamukkale University, Denizli, Turkey.

出版信息

Horm Mol Biol Clin Investig. 2022 Apr 11;43(3):281-288. doi: 10.1515/hmbci-2021-0074. eCollection 2022 Sep 1.

DOI:10.1515/hmbci-2021-0074
PMID:35405046
Abstract

OBJECTIVES

Vitamin D is an important regulator of the immune system, and it has been shown that deficiency of vitamin D is significant environmental factor in some immune-mediated diseases such as Multiple Sclerosis (MS). In this study, we have compared serum 25 hydroxyvitamin (OH) D levels in Relapsing-Remitting Multiple Sclerosis (RRMS), clinically isolated syndrome (CIS), and control groups.

METHODS

Forty patients with CIS and 60 patients who have been diagnosed RRMS between age 18-45, respectively, and followed up at Pamukkale University Faculty of Medicine, Department of Neurology, and 60 healthy individuals have been included in this study. Serum 25(OH) vitamin D, calcium, phosphorus, alkaline phosphatase, parathormone, insulin, and fasting blood glucose levels were studied for all three groups.

RESULTS

A statistically significant difference was determined in the comparison of three groups for mean 25(OH) vitamin D levels. In the intergroup comparison of mean 25(OH) vitamin D; mean 25(OH) vitamin D level was determined to be statistically significantly lower in both RRMS and CIS groups compared to control group (p<0.05).

CONCLUSIONS

Since vitamin D deficiency poses a problem from the early stage of disease spectrum in both CIS patients and MS patients, 25(OH) vitamin D level should be routinely controlled, and replacement should be administered upon any deficiency state.

摘要

目的

维生素D是免疫系统的重要调节因子,已有研究表明,维生素D缺乏是多发性硬化症(MS)等一些免疫介导疾病的重要环境因素。在本研究中,我们比较了复发缓解型多发性硬化症(RRMS)、临床孤立综合征(CIS)和对照组的血清25-羟维生素(OH)D水平。

方法

本研究纳入了40例CIS患者和60例年龄在18 - 45岁之间、在棉花堡大学医学院神经科随访的RRMS患者,以及60名健康个体。对三组患者均检测血清25(OH)维生素D、钙、磷、碱性磷酸酶、甲状旁腺激素、胰岛素和空腹血糖水平。

结果

三组患者的平均25(OH)维生素D水平比较存在统计学显著差异。在平均25(OH)维生素D的组间比较中,RRMS组和CIS组的平均25(OH)维生素D水平均显著低于对照组(p<0.05)。

结论

由于维生素D缺乏在CIS患者和MS患者疾病谱的早期阶段就构成问题,应常规检测25(OH)维生素D水平,一旦出现缺乏状态就应进行补充。

相似文献

1
Serum 25(OH) vitamin D level in Relapsing-Remitting Multiple Sclerosis and clinically isolated syndrome groups.复发缓解型多发性硬化症组和临床孤立综合征组的血清25(OH)维生素D水平。
Horm Mol Biol Clin Investig. 2022 Apr 11;43(3):281-288. doi: 10.1515/hmbci-2021-0074. eCollection 2022 Sep 1.
2
Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.甲状旁腺激素-成纤维细胞生长因子 23-维生素 D 轴在复发缓解型多发性硬化中的失衡:一项纵向研究。
Mol Med. 2018 May 30;24(1):27. doi: 10.1186/s10020-018-0028-3.
3
A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.一项关于血清25-羟基维生素D和完整甲状旁腺激素水平的纵向研究表明了维生素D和钙稳态调节在多发性硬化症中的重要性。
J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152-7. doi: 10.1136/jnnp.2006.105320. Epub 2007 Jun 19.
4
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.诊断时维生素D水平低与早期转变为继发进展型多发性硬化症有关。
J Steroid Biochem Mol Biol. 2016 Nov;164:254-257. doi: 10.1016/j.jsbmb.2015.11.009. Epub 2015 Nov 17.
5
Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.调节性 T 细胞功能与血清 25-羟维生素 D 相关,但与 1,25-二羟维生素 D、甲状旁腺激素和钙水平在复发缓解型多发性硬化症患者中不相关。
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):243-6. doi: 10.1016/j.jsbmb.2010.03.001. Epub 2010 Mar 6.
6
Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.维生素 D 补充剂可降低那他珠单抗治疗的复发缓解型多发性硬化患者的复发率。
Mult Scler Relat Disord. 2016 Nov;10:169-173. doi: 10.1016/j.msard.2016.10.005. Epub 2016 Oct 26.
7
Concentration of 25(OH)D₃ and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study.复发缓解型多发性硬化症患者的 25(OH)D₃ 浓度与钙磷代谢。一项初步研究。
Neurol Neurochir Pol. 2013 Mar-Apr;47(2):126-30. doi: 10.5114/ninp.2013.34730.
8
Calcium-phosphate metabolism in patients with multiple sclerosis.多发性硬化症患者的钙磷代谢
J Endocrinol Invest. 2015 Jun;38(6):635-42. doi: 10.1007/s40618-014-0235-x. Epub 2015 Jan 18.
9
Immunomodulatory effects of Vitamin D in multiple sclerosis.维生素D在多发性硬化症中的免疫调节作用。
Brain. 2009 May;132(Pt 5):1146-60. doi: 10.1093/brain/awp033. Epub 2009 Mar 24.
10
Bone metabolism and vitamin D status in patients with multiple sclerosis.多发性硬化症患者的骨代谢与维生素D状态
Neurol Neurochir Pol. 2016 Jul-Aug;50(4):251-7. doi: 10.1016/j.pjnns.2016.04.010. Epub 2016 Apr 27.

引用本文的文献

1
Breaking the Cycle: Can Vitamin D Bridge the Gap Between Gut Microbiota and Immune Dynamics in Multiple Sclerosis?打破循环:维生素D能否弥合多发性硬化症中肠道微生物群与免疫动力学之间的差距?
Int J Mol Sci. 2025 Jun 7;26(12):5464. doi: 10.3390/ijms26125464.
2
Association between insulin resistance and multiple sclerosis: a systematic review and meta-analysis.胰岛素抵抗与多发性硬化症的相关性:系统评价和荟萃分析。
Metab Brain Dis. 2024 Jun;39(5):1015-1026. doi: 10.1007/s11011-024-01347-2. Epub 2024 May 20.